CLINICAL_TRIALS
trial_result
· 2022-12-28
Clinical Trial Update: Neoadjuvant Carboplatin in Triple Negative Breast Cancer [Phase 2]
Summary
Phase 2 trial update evaluating neoadjuvant carboplatin in triple-negative breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Barretos Cancer Hospital | Conditions: BRCA1 Hereditary Breast and Ovarian Cancer Syndrome | Phase 2 | Status: COMPLETED